University Of Notre Dame Du Lac Dexcom Inc Transaction History

University Of Notre Dame Du Lac

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $532,544 - $724,350	-18,972 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$26.99 - $37.37 $76,597 - $106,056	-2,838 Reduced 13.01%	18,972 $2.27 Million
Q3 2018 Nov 13, 2018	SELL	$23.35 - $36.72 $226,308 - $355,890	-9,692 Reduced 30.77%	21,810 $3.12 Million
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $283,551 - $407,706	-16,166 Reduced 33.91%	31,502 $2.99 Million
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $622,544 - $883,764	47,668 New	47,668 $3.54 Million

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.